Double-blind study of pulsing magnetic field effects on multiple sclerosis

Journal of Alternative and Complementary Medicine

Volumn 3, Issue 1, 1997, Pages 21-29

  Richards, T L ^a,d,e   Lappin, M S ^b   Acosta Urquidi, J ^a   Kraft, G H ^a   Heide, A C ^a   Lawrie, F W ^c   Merrill, T E ^a   Melton, G B ^a   Cunningham, C A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Alternative Health Care   (United States)

^c Energy Medicine Developments Inc   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; HUMAN; LANGUAGE; LOCOMOTION; MAGNETISM; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VISION;

COGNITION; COMPLEMENTARY THERAPIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; LANGUAGE; LOCOMOTION; MAGNETICS; MULTIPLE SCLEROSIS; VISION;

EID: 0031089253     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.1997.3.21     Document Type: Article

References (29)

1. Barlow JS. (1993). The Electroencephalogram: Its Pattern and Origins. The MIT Press, Cambridge, MA.
2. Beers GJ. Biological effects of weak electromagnetic fields from 0 Hz to 200 MH: A survey of the literature with special emphasis on possible magnetic reasonance effects. Magn Resonance Imag 1989 7: 309-331.
3. Bell GB, Marino AA, Chesson AL. Alerations in brain electrical activity caused by magnetic fields: Detecting the detection process. Electroencephalogr Clin Neurophysiol 1992 83: 389-397.
4. Brau H, Ulrich G. Electroencephalographic vigilance dynamics in multiple sclerosis during an acute episode and after remission. Eur Arch Psychiatry Neurol Sci 1990 239: 320-324.
5. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996 23: 99-103.
6. Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, Chang C, Lloyd S, Steward J, Stefoski K. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996 47: 129-130.
7. Frey AH. Electromagnetic field interactions with biological systems. FASEB J 1992 7: 272-281.
8. Guseo A. Pulsing electromagnetic field therapy of multiple sclerosis by the Gyuling-Bordacs device: Double-blind, cross-over and open studies. J. Bioelect. 1987 6: 23-35.
9. Hermann BP, Vickrey B, Hays RD, Cramer J, Devinsky O, Meader K, Perrine K, Myers LW, Ellison GW. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 1996 25: 113-118.
10. Horrigan B. Bruce Pomeranz, acupuncture and the raison d'etre for alternative medicine. Alternative Ther in Med 1996 2: 85-91.
11. Jonsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand 1996 93: 229-235.
12. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983 33: 1444-1452.
13. Lankhorst GJ, Jelles F, Smits RCF, Polman CH, Kuik DJ, Pfennings LEMA, Cohen L, vanderPloeg HM, Ketelaer P, Vleugels L. Quality of life in multiple sclerosis: The disability and impact profile (DIP). J Neurol 1996 243: 469-474.
14. Lebet JP, Barbault A, Rossel C, Tomic Z, Reite M, Higgs L, Dafni U, Amato D, Pasche B. Electroencephalographic changes following low energy emission therapy. Ann Biomed Eng 1996 24: 424-429.
15. Lyskov EB, Juutilainen J, Jousmaki V, Partanen J, Medvedev S, Hanninen O. Effects of 45-Hz magnetic fields on the functional state of the human brain. Bioelectromagnetics 1993 14: 87-95.
16. Malone M, Lomaestro B. Outcomes assessment of drug treatment in multiple sclerosis clinical trials. Pharmacoeconomics 1996 9: 198-210.
17. Persinger MA, Richards PM, Koren SA. Differential ratings of pleasantness following right and left hemispheric application of low energy magnetic fields that stimulate long-term potentiation. Int J Neurosci 1994 79: 191-197.
18. Pentajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996 39: 432-441.
19. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davies FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983 13:227-231.
20. Reiter RJ. Electromagnetic fields and melatonin production. Biomed Pharmacother 1993 47: 439-444.
21. Reiter RJ. Melatonin suppression by static and extremely low frequency electromagnetic fields: Relationship to the reported increased incidence of cancer. Rev Environ Health 1994 10: 171-186.
22. Sandyk R. Rapid normalization of visual evoked potentials by picoTesla range magnetic fields in chronic progressive multiple sclerosis. Int J Neurosci 1994 77: 243-259.
23. Schwartz CE, Vollmer T, Zeng Q, Sclerosis TNARcom. New outcome measures for MS clinical research: The Symptom Inventory and the Performance Scales [Abstract]. Neurology 1996 46 (Suppl): A321.
24. Sugano H, Uchida S, Kuramoto I. A new approach to the studies of subtle energies. Subtle Energies 1994 5: 143-166.
25. Tiller SG, Persinger MA. Enhanced hypnotizability by cerebrally applied magnetic fields depends upon the order of hemispheric presentation: An anistropic effect. Int J Neurosci 1994 79: 157-163.
26. Walleczek J. Electromagnetic field effects on cells of the immune system: The role of calcium signaling. FASEB J 1992 6: 3177-3185.
27. 2+ uptake in rat thymocytes: Dependence on mitogen activation. FEBS Lett 1990 271: 157-160.
28. Walpole S. Medigen and brain frequency analyser. Int J Altern Comp Med 1993 Oct., 23-26.
29. Watahiki Y, Baba M, Matsunaga M, Takebe K, Onuma T. Sympathetic skin response in diabetic neuropathy. Electromyogr Clin Neurophysiol 1989 29: 155-159.